Strong global IPO momentum in 2026, with 267 U.S. listings raising substantial proceeds through mid-November, reflects resilient equity markets, selective investor demand for profitable growth companies, and sector rotation into AI infrastructure, biotech, and consumer names. Mega-deals such as SpaceX earlier in the year and Anthropic’s $61–74 billion offering—now in roadshow with pricing expected around November 19—have anchored activity, while smaller filings continue to clear. Recent November 13 pricing of multiple deals and a deep pipeline of amended S-1s signal sustained issuance before year-end. Key near-term catalysts include Anthropic’s outcome, post-election market stability, and any shifts in interest-rate expectations that could influence valuation multiples and deal timing into 2027.